InvestSMART

Mesoblast Limited (ASX: MSB) - Announcements

Current share price for MSB : $2.590 0.21 (8.82%)+

ASX company news and announcements for Mesoblast Limited (MSB) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Mesoblast Limited (MSB) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Mesoblast Limited (MSB), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Mesoblast Limited (MSB)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$3,353 Key Australian Adult Stem Cell Patent Granted 17 Jan 2006 11:04AM $1.200 $2.590 risen by 115.83%
$3,353 Australian Government awards $2.7m 21 Dec 2005 9:21AM $1.160 $2.590 risen by 123.28%
$3,353 Adult Stem Cell Heart Trial Update 19 Dec 2005 9:59AM $1.130 $2.590 risen by 129.20%
$3,353 First Patients Recruited for Mesoblast Pilot Clinical Trials 7 Dec 2005 8:40AM $1.080 $2.590 risen by 139.81%
$3,353 2006 To Be An Extraordinary Year 15 Nov 2005 8:30AM $1.220 $2.590 risen by 112.30%
$3,353 MSB and J & J Join Forces in Adult Stem Cell Heart Trials 7 Nov 2005 8:54AM $1.190 $2.590 risen by 117.65%
$3,353 Commitments Test Entity - First Quarter Report 31 Oct 2005 9:09AM $1.040 $2.590 risen by 149.04%
$3,353 Accelerates timetable for Clinical Trials & Reg Approval 17 Oct 2005 10:01AM $0.860 $2.590 risen by 201.16%
$3,353 World First Adult Stem Cell Trial Approved 23 Sep 2005 8:29AM $0.580 $2.590 risen by 346.55%
$3,353 Initiates commercial manufacture of adult stem cells 20 Sep 2005 11:59AM $0.540 $2.590 risen by 379.63%
$3,353 Preliminary Final Report & Annual Report 13 Sep 2005 10:19AM $0.500 $2.590 risen by 418%
$3,353 Agreement signed with Major International Medical Company 24 Aug 2005 10:42AM $0.505 $2.590 risen by 412.87%
$3,353 Commitments Test Entity - Fourth Quarter Report 1 Aug 2005 8:31AM $0.440 $2.590 risen by 488.64%
$3,353 Colorado State University to Trial for Bone Regeneration 21 Jul 2005 9:08AM $0.500 $2.590 risen by 418%
$3,353 Targets United States Investor Base 5 Jul 2005 10:17AM $0.480 $2.590 risen by 439.58%
$3,353 Rapid prog towards adult stem cell human clinical trials 31 Mar 2005 8:57AM $0.590 $2.590 risen by 338.98%
$3,353 Contract Cell Processing Facility for Pilot Clinical Trials 15 Feb 2005 8:29AM $0.690 $2.590 risen by 275.36%

1151 - 1167 of 1167 results

Page 47 of 47

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.